Key terms
About HQY
HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest HQY news
Today
7:55am ET
Jefferies Keeps Their Buy Rating on Healthequity (HQY)
Today
4:55am ET
Buy Rating on Healthequity (HQY) Affirmed Amid HSA Market Growth and Competitive Outperformance
Mar 26
8:02pm ET
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE)
Mar 24
2:01am ET
Navigating Uncertainty: Healthequity Inc. Grapples with HSA Asset Volatility and Revenue Risks
Mar 22
9:15am ET
HealthEquity Outperforms with Strong Quarterly Results and Positive Fiscal 2025 Outlook: Buy Rating Reaffirmed
Mar 22
6:23am ET
HealthEquity price target raised to $95 from $85 at KeyBanc
Mar 22
3:40am ET
Analysts’ Top Healthcare Picks: Healthequity (HQY), Exscientia Plc (EXAI)
Mar 21
2:36am ET
HealthEquity: A Strong Buy with Projected Earnings Growth and Market Leadership
Mar 20
1:47pm ET
HealthEquity price target raised to $110 from $100 at BTIG
Mar 20
7:47am ET
HealthEquity price target raised to $92 from $90 at RBC Capital
Mar 20
7:15am ET
Healthequity (HQY) Receives a Buy from RBC Capital
Mar 20
6:22am ET
HealthEquity price target raised to $97 from $93 at BofA
Mar 20
6:01am ET
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Coya Therapeutics, Inc. (COYA) and Iovance Biotherapeutics (IOVA)
Mar 20
5:10am ET
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Shockwave Medical (SWAV) and Healthequity (HQY)
Mar 20
3:15am ET
Barclays Keeps Their Buy Rating on Healthequity (HQY)
Mar 19
4:11pm ET
HealthEquity sees FY25 EPS $2.79-$2.96, consensus $2.83
Mar 19
4:06pm ET
HealthEquity reports Q4 EPS 63c, consensus 56c
Mar 19
1:45am ET
HealthEquity (HQY) Poised for Strong Growth and Resilience, Earns ‘Buy’ Rating
Mar 14
6:16am ET
Healthequity’s Financial Growth and Strategic Asset Management Shift Justify a Buy Rating
Mar 13
4:23pm ET
HealthEquity Expands HSA Market Share with Strategic Acquisition
Feb 26
9:06am ET
HealthEquity price target raised to $100 from $85 at Barrington
Feb 23
10:02am ET
HealthEquity price target raised to $90 from $77 at RBC Capital
Feb 23
7:40am ET
Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), Insulet (PODD) and Healthequity (HQY)
Feb 23
7:38am ET
HealthEquity raises FY24 EPS view to $2.20-$2.24 from $2.08-$2.16
Feb 23
7:34am ET
HealthEquity price target raised to $100 from $85 at BTIG
Feb 23
7:05am ET
HealthEquity price target raised to $97 from $92 at Baird
Feb 23
5:46am ET
HealthEquity price target raised to $104 from $84 at Barclays
Feb 23
5:15am ET
Buy Rating Affirmed for HealthEquity: A Path to Doubling EPS Through Strategic Growth and Innovation
Feb 23
3:15am ET
Barclays Sticks to Its Buy Rating for Healthequity (HQY)
Feb 22
10:30am ET
HealthEquity to host investor day
Feb 22
5:36am ET
Healthequity: A Strong Buy on Robust Financial Outlook and Consistent Performance
No recent news articles are available for HQY
No recent press releases are available for HQY
HQY Financials
Key terms
Ad Feedback
HQY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
HQY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range